Single-Use Technologies for Biopharmaceuticals: Global Markets
Upcoming SlideShare
Loading in...5
×
 

Single-Use Technologies for Biopharmaceuticals: Global Markets

on

  • 360 views

 

Statistics

Views

Total Views
360
Views on SlideShare
360
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Single-Use Technologies for Biopharmaceuticals: Global Markets Single-Use Technologies for Biopharmaceuticals: Global Markets Document Transcript

  • Single-Use Technologies for Biopharmaceuticals: GlobalMarketsReport Details:Published:January 2013No. of Pages: 138Price: Single User License – US$5450REPORT HIGHLIGHTSThis report provides:•An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters•Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017•In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges•Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs•Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares•Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns•Comprehensive company profiles of existing and potential market players•Patent analysis.REPORT SCOPEINTRODUCTIONSTUDY BACKGROUNDEliminating the risk of contamination is the greatest challenge faced by manufacturers ofbiopharmaceuticals, and currently this requires high level monitoring of critical manufacturingprocesses. Single-use technology (SUT) aids biopharmaceutical manufacturers in overcomingthis challenge by reducing or eliminating the need for sterilization between batches, therebyimproving operational efficiency. Time to market for biopharmaceutical drugs is extremelyimportant given the developmental costs involved. Single-use technologies help lower these costsby reducing the number of validation steps and also shorten the length of the production process.Growth of single-use technologies in biopharmaceutical manufacturing is expected to be
  • significant over the forecast period due to the increasing evidence of their cost-saving benefits.STUDY GOALS AND OBJECTIVESThe objective of the report is to provide an intensive assessment of the market for single-usetechnologies specifically used in biopharmaceutical production. Specific goals include:•Identifying key technologies, applications and end-user segments that are expected to achieve significant sales by 2017 with respect to single-use technologies.•Assessing and identifying the key market dynamics that drive and restrain growth, markets that provide lucrative opportunities and factors that pose challenges to market participants.•To understand and provide details with respect to market intelligence, key market participants and top strategies adopted by SUT players.•Market estimates through 2017.•Identifying and profiling key companies and patents.INTENDED AUDIENCEThe report provides an in-depth study of the following supply chain participants: contractmanufacturing organizations, biopharmaceutical companies/manufacturers and systemintegrators. The study includes a product portfolio analysis, case studies, market estimates andrecent developments, which will be immensely useful to SUT manufacturers and academia. Thereport presents an in-depth-patent analysis of single-use technologies used in the manufacture ofbiopharmaceuticals. Single-use technologies currently under investigation or newly approved foruse by the Food and Drug Administration (FDA) are also discussed.SCOPE AND FORMATThe report includes the following key market segments:•Single-use bioreactors (SUBs).•Membrane adsorbers.•Mixing.•Tangential flow filtration.•Tubing.•Connectors.•Preassembled tubing and rigging.•Depth filtration.•Buffer containers.•Waste containers.•Samplers.•Media bags.•Filter cartridges and other key markets.The study includes the following major elements:•Executive summary.•Revenues forecast through 2017.•Analysis of the key factors influencing market demand.•Market intelligence.•Key trends across geographies.
  • •Key trends, opportunities and market estimates within each of the markets specified.•General assessment of expected market trends in the longer term (2012 to 2017).•Competitive environment—Key companies, top strategies and recent developments and market intelligence.•Company profiles.•Patent analysis.Specifically excluded from the report are market estimates of biopharmaceutical drugs anddevices. However, an overview of the market for biopharmaceutical drugs is given to provide aholistic view of the market. The report covers only single-use technologies or disposables used inbiopharmaceutical manufacturing. The report also excludes control software or custom designedsoftware used with single-use biopharmaceutical manufacturing technologies.INFORMATION SOURCE AND METHODOLOGYInformation sources were derived through both primary and secondary research. Secondarysources included government websites, industry associations, company websites,biopharmaceutical magazines and recent conferences. Primary research was conducted toevaluate the market quantitatively as well as qualitatively and its impact on market growth. Thegreatest challenges were in deriving the revenues for micro markets; however, that was achievedthrough an intensive study of historical sales, current adoption levels and expected future marketpotential validated through primary research.Growth within the SUT market is significantly varied, as some technologies are increasing at acompounded annual growth rate (CAGR) of nearly 35% with some technologies increasing at aCAGR below 5% through the forecast period. Therefore, an analysis of comparative marketgrowth has been performed.Get your copy of this report @http://www.reportsnreports.com/reports/213060-single-use-technologies-for-biopharmaceuticals-global-markets.htmlMajor points covered in Table of Contents of this report includeTABLE OF CONTENTSChapter- 1: INTRODUCTIONSTUDY BACKGROUNDSTUDY GOALS AND OBJECTIVESINTENDED AUDIENCESCOPE AND FORMATINFORMATION SOURCE AND METHODOLOGYANALYST CREDENTIALSRELATED BCC RESEARCH REPORTSBCC ONLINE SERVICESDISCLAIMERChapter- 2: SUMMARYTable Summary : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THE
  • MANUFACTURE OF BIOPHARMACEUTICALS BY GEOGRAPHIC REGION, THROUGH 2017Figure Summary : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY GEOGRAPHIC REGION, 2011-2017Chapter- 3: MARKET OVERVIEWBRIEF HISTORY OF BIOPROCESS DISPOSABLESMARKET DYNAMICSSTAINLESS STEEL PROCESSORS VERSUS DISPOSABLES IN BIOPHARMACEUTICALMANUFACTUREBIOPHARMACEUTICAL INDUSTRY TRENDS: STEADY TRANSITION FROMPHARMACEUTICALS TO BIOPHARMACEUTICALSChapter- 4: MARKET BY TECHNOLOGYMEMBRANE ADSORBERBIOREACTORSDISPOSABLE MIXING SYSTEMSTANGENTIAL FLOW FILTRATIONTUBING AND CONNECTORSPREASSEMBLED TUBING AND RIGGINGDEPTH FILTRATIONBUFFER CONTAINERSWASTE CONTAINERSSAMPLERSMEDIA BAGS AND FILTER CARTRIDGESOTHER SINGLE-USE TECHNOLOGIESTable 4 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGY USED IN THE MANUFACTUREOF BIOPHARMACEUTICALS BY SEGMENT, THROUGH 2017Chapter- 5: MARKET BY APPLICATIONMONOCLONAL ANTIBODIESVACCINESGENE THERAPYRECOMBINANT PROTEINSBLOOD DERIVATIVESANTICANCER DRUGSOTHERSTable 26 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGY FOR USE INBIOPHARMACEUTICAL MANUFACTURE BY APPLICATION, THROUGH 2017Chapter- 6: MARKET BY END USERSCMOS VERSUS BIOPHARMACEUTICAL MANUFACTURERSR&DGMPTable 34 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY END USER, 2012–2017
  • Chapter- 7: MARKET STRATEGIES AND COMPETITIVE ENVIRONMENTPRODUCT LAUNCHES: TOP STRATEGYTOP COMPANIES FOCUS ON COLLABORATIONS THROUGH MERGERS ANDACQUISITIONS AND AGREEMENTSANALYSIS BY COMPANYChapter- 8: GEOGRAPHIC ANALYSIS, LEGISLATION AND GOVERNMENT INITIATIVES-FOCUS ON EMERGING ECONOMIESTHE AMERICASEUROPEASIAChapter- 9: COMPANY PROFILESADVANCED SCIENTIFICS INC.ADVANTAPUREAPPLIKON BIOTECHNOLOGYATMI LIFESCIENCESATOLLBARBLOCKBIOPHARMA DYNAMICSBIOPUREBOSCH PACKAGINGCELLONCHARTER MEDICALCMC BIOLOGICSCOLDER PRODUCTS CO.DOW CORNINGEMD MILLIPOREFINESSE SOLUTIONSGE HEALTHCAREGOREIS SUPPLIESNOVASEPPALL CORP.PENDOTECHRENOLITREPLIGEN BIOPROCESSINGSAINT GOBAINSARTORIUSTARPON BIOSYSTEMSXCELLEREXChapter- 10: APPENDIX ONE: GLOBAL MARKET FOR STORAGE BUFFER CONTAINERS,AND U.S. PATENTS FOR SUT, 2010 TO 2012Table 92 : GLOBAL MARKET FOR STORAGE BUFFER CONTAINERS BY GEOGRAPHIC
  • REGION, THROUGH 2017Table 93 : GLOBAL MARKET FOR PREPARATION BUFFER CONTAINERS BY GEOGRAPHICREGION, THROUGH 2017Table 94 : U.S. PATENTS FOR SUT, 2010 TO 2012Table 95 : EUROPEAN SUT PATENTS, 2010 TO 2012Chapter- 11: APPENDIX TWO: LIST OF ACRONYMSLIST OF TABLESSummary Table : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY GEOGRAPHIC REGION, THROUGH 2017Table 1 : DEVELOPMENTS IN SINGLE-USE TECHNOLOGIESTable 2 : SUT GAP ANALYSISTable 3 : BIOREACTOR FACILITY COSTS: SINGLE-USE VERSUS STAINLESS STEELSYSTEMSTable 4 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGY USED IN THE MANUFACTUREOF BIOPHARMACEUTICALS BY SEGMENT, THROUGH 2017Table 5 : GLOBAL MARKET FOR MEMBRANE ADSORBERS BY GEOGRAPHIC REGION,2012–2017Table 6 : GLOBAL MARKET FOR BIOREACTORS BY TECHNOLOGY, THROUGH 2017Table 7 : GLOBAL MARKET FOR BIOREACTORS BY GEOGRAPHIC REGION, THROUGH 2017Table 8 : GLOBAL MARKET FOR SEED BIOREACTORS BY GEOGRAPHIC REGION,THROUGH 2017Table 9 : GLOBAL MARKET FOR PRODUCTION BIOREACTORS BY GEOGRAPHIC REGION,THROUGH 2017Table 10 : GLOBAL MARKET FOR DISPOSABLE MIXING SYSTEMS BY GEOGRAPHICREGION, THROUGH 2017Table 11 : GLOBAL MARKET FOR TANGENTIAL FLOW FILTRATION SYSTEMS BYGEOGRAPHIC REGION, THROUGH 2017Table 12 : GLOBAL MARKET FOR TUBING BY GEOGRAPHIC REGION, THROUGH 2017Table 13 : GLOBAL MARKET FOR CONNECTORS BY GEOGRAPHIC REGION, 2012–2017Table 14 : GLOBAL MARKET FOR PREASSEMBLED TUBING AND RIGGING BYGEOGRAPHIC REGION, THROUGH 2017Table 15 : GLOBAL MARKET DEPTH FILTRATION SYSTEMS BY GEOGRAPHIC REGION,THROUGH 2017Table 16 : GLOBAL MARKET FOR BUFFER CONTAINERS BY EQUIPMENT TYPE, THROUGH2017Table 17 : GLOBAL MARKET FOR BUFFER CONTAINERS BY GEOGRAPHIC REGION,THROUGH 2017Table 18 : GLOBAL MARKET FOR WASTE CONTAINERS BY GEOGRAPHIC REGION,THROUGH 2017Table 19 : GLOBAL MARKET FOR SAMPLERS BY GEOGRAPHIC REGION, THROUGH 2017Table 20 : GLOBAL MARKET FOR MEDIA BAGS BY TYPE, THROUGH 2017Table 21 : GLOBAL MARKET FOR MEDIA BAGS BY GEOGRAPHIC REGION, 2012–2017
  • Table 22 : GLOBAL MARKET FOR FILLED MEDIA BAGS BY GEOGRAPHIC REGION,THROUGH 2017Table 23 : GLOBAL MARKET FOR DRY MEDIA BAGS BY GEOGRAPHIC REGION, THROUGH2017Table 24 : GLOBAL MARKET FOR FILTER CARTRIDGES BY GEOGRAPHIC REGION,THROUGH 2017Table 25 : GLOBAL MARKET FOR OTHER SINGLE-USE TECHNOLOGIES BY GEOGRAPHICREGION, THROUGH 2017Table 26 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGY FOR USE INBIOPHARMACEUTICAL MANUFACTURE BY APPLICATION, THROUGH 2017Table 27 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEPRODUCTION OF MONOCLONAL ANTIBODIES, THROUGH 2017Table 28 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEPRODUCTION OF VACCINES, THROUGH 2017Table 29 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN GENE THERAPY,THROUGH 2017Table 30 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEPRODUCTION OF RECOMBINANT PROTEIN, THROUGH 2017Table 31 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BLOOD DERIVATIVES, THROUGH 2017Table 32 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF ANTICANCER DRUGS, THROUGH 2017Table 33 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN OTHERAPPLICATION AREAS, THROUGH 2017Table 34 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY END USER, 2012–2017Table 35 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED BYBIOPHARMACEUTICAL CMOS, THROUGH 2017Table 36 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED BYBIOPHARMACEUTICAL MANUFACTURERS BY REGION, THROUGH 2017Table 37 : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY END USER SEGMENT, THROUGH 2017Table 38 : GLOBAL R&D SPENT ON SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY GEOGRAPHIC REGION, THROUGH 2017Table 39 : GLOBAL EXPENDITURES ON GOOD MANUFACTURING PRACTICES FORSINGLE-USE TECHNOLOGIES USED IN THE MANUFACTURE OF BIOPHARMACEUTICALSBY REGION, THROUGH 2017Table 40 : COMPANY STRATEGIESTable 41 : COMPANY ANNOUNCEMENTS, 2006 TO JULY 2012Table 42 : ADVANCED SCIENTIFICS INC.: PRODUCT PORTFOLIOTable 43 : ADVANTAPURE: PRODUCT PORTFOLIOTable 44 : ADVANTAPURE: RECENT DEVELOPMENTS, 2011–2012
  • Table 45 : APPLIKON BIOTECHNOLOGY: PRODUCT PORTFOLIOTable 46 : APPLIKON BIOTECHNOLOGY: RECENT DEVELOPMENTSTable 47 : ATMI LIFESCIENCES: PRODUCT PORTFOLIOTable 48 : ATMI LIFESCIENCES: RECENT DEVELOPMENTS, 2006-2012Table 49 : ATMI LIFESCIENCES: FINANCIALS, 2008–2010Table 50 : ATOLL: PRODUCT PORTFOLIOTable 51 : BARBLOCK: PRODUCT PORTFOLIOTable 52 : BIOPHARMA DYNAMICS: PRODUCT PORTFOLIOTable 53 : BIOPURE: PRODUCT PORTFOLIOTable 54 : BIOPURE: RECENT DEVELOPMENTSTable 55 : BOSCH PACKAGING: PRODUCT PORTFOLIOTable 56 : BOSCH PACKAGING: RECENT DEVELOPMENTSTable 57 : CELLON: PRODUCT PORTFOLIOTable 58 : CELLON: RECENT DEVELOPMENTSTable 59 : CHARTER MEDICAL: PRODUCT PORTFOLIOTable 60 : CHARTER MEDICAL: RECENT DEVELOPMENTSTable 61 : CMC BIOLOGICS: SERVICESTable 62 : CMC BIOLOGICS: RECENT DEVELOPMENTSTable 63 : COLDER PRODUCTS COMPANY: PRODUCT PORTFOLIOTable 64 : COLDER PRODUCTS CO.: RECENT DEVELOPMENTS, 2011-2012Table 65 : DOW CORNING: PRODUCT PORTFOLIOTable 66 : DOW CORNING: RECENT DEVELOPMENTS, 2009-2011Table 67 : EMD MILLIPORE: PRODUCT PORTFOLIOTable 68 : EMD MILLIPORE: RECENT DEVELOPMENTS, 2006-2012Table 69 : FINESSE SOLUTIONS: PRODUCT PORTFOLIOTable 70 : FINESSE SOLUTIONS: RECENT DEVELOPMENTS, 2009-2011Table 71 : GE HEALTHCARE: PRODUCT PORTFOLIOTable 72 : GORE: PRODUCT PORTFOLIOTable 73 : GORE: RECENT DEVELOPMENTS, 2011-2012Table 74 : IS SUPPLIES: PRODUCT PORTFOLIOTable 75 : NOVASEP: PRODUCT PORTFOLIOTable 76 : NOVASEP: RECENT DEVELOPMENTS, 2011-2012Table 77 : PALL CORP. PRODUCT PORTFOLIOTable 78 : PALL CORP.: RECENT DEVELOPMENTS, 2011-2012Table 79 : PENDOTECH: PRODUCT PORTFOLIOTable 80 : PENDOTECH: RECENT DEVELOPMENTS, 2011-2012Table 81 : RENOLIT: PRODUCT PORTFOLIOTable 82 : RENOLIT: RECENT DEVELOPMENTSTable 83 : REPLIGEN BIOPROCESSING: PRODUCT PORTFOLIOTable 84 : SAINT GOBAIN: PRODUCT PORTFOLIOTable 85 : SAINT GOBAIN: RECENT DEVELOPMENTS, 2011-2012Table 86 : SARTORIUS: PRODUCT PORTFOLIO
  • Table 87 : SARTORIUS: RECENT DEVELOPMENTS, 2011-2012Table 88 : SARTORIUS: FINANCIALSTable 89 : TARPON BIOSYSTEMS: PRODUCT PORTFOLIOTable 90 : XCELLEREX: PRODUCT PORTFOLIOTable 91 : XCELLEREX: RECENT DEVELOPMENTS, 2011-2012Table 92 : GLOBAL MARKET FOR STORAGE BUFFER CONTAINERS BY GEOGRAPHICREGION, THROUGH 2017Table 93 : GLOBAL MARKET FOR PREPARATION BUFFER CONTAINERS BY GEOGRAPHICREGION, THROUGH 2017Table 94 : U.S. PATENTS FOR SUT, 2010 TO 2012Table 95 : EUROPEAN SUT PATENTS, 2010 TO 2012LIST OF FIGURESSummary Figure : GLOBAL MARKET FOR SINGLE-USE TECHNOLOGIES USED IN THEMANUFACTURE OF BIOPHARMACEUTICALS BY GEOGRAPHIC REGION, 2011-2017Figure 1 : EVOLUTION OF SINGLE-USE TECHNOLOGIES USED IN BIOPHARMACEUTICALMANUFACTURINGFigure 2 : COST OF NEW DRUG DEVELOPMENT, 1997-2013Figure 3 : GROWTH ANALYSIS OF THE SUT MARKETFigure 4 : THE U.S. AND EUROPEAN PATENTS ON SINGLE-USE TECHNOLOGIES, 2010-2012Figure 5 : U.S. PATENTS ON SINGLE-USE TECHNOLOGIES BY YEAR, 2010 TO JUNE 2012Figure 6 : EUROPEAN PATENTS BY YEAR, 2010 TO JUNE 2012Figure 7 : BIOPHARMACEUTICAL MANUFACTURE OF MONOCLONAL ANTIBODIESFigure 8 : SELECTED AVERAGE FACILITY BUDGETS FOR SINGLE-USE DEVICES-BIOTHERAPEUTICS DEVELOPERS VS. CMOSFigure 9 : TOP STRATEGIES, 2006-2012Figure 10 : AGREEMENTS BY COMPANY, 2006-2012Figure 11 : MERGERS AND ACQUISITIONS BY COMPANY, 2006-2012Figure 12 : ANALYSIS BY COMPANY 2006-2012Contact: sales@reportsandreports.com for more information.